Agenda-2012

9:00 -10:00

Registration and Exhibitions

10:00 - 10:05

Welcome & Opening Remarks
Dr. Peiwen Yu, President of CBA

10:05 - 10:10

Introduction
Dr. Son Kuan, Conference Chairperson
Session I (10:10am – 12:10pm)

10:10 - 10:40

The 24 Characteristics of the Genius Entrepreneur presented by Mr. Robert W. Duggan, CEO & Chairman of the Board of Directors at Pharmacyclics

10:40 - 11:10

The Science and Business of Drug Development: Proteolix and Carfilzomib presented by Dr. Christopher J. Molineaux, Drug Development Consultant, INDStrat LLC.

11:10 - 11:40

Globalizing Traditional Chinese Medicine presented by Ms. Helen Chen, Partner and Head of L.E.K’s China Life Sciences Practice

11:40 – 12:10

China Life Sciences:  The Bridge Goes Both Ways presented by Dr. Chen Yu, Managing Partner at Vivo Ventures

12:10 – 12:25

Break, Networking and Exhibitions
Session II (12:25 pm - 1:25 pm)

12:25 - 12:55

China and Its 5000 Years of Science, Culture, and Creativity presented by Dr. Vincent Yip, Lecturer at Stanford Continuing Studies

12:55 – 1:25

The Art of Striking Cross-Border Collaboration with China presented by Dr. Karen K. Wong, IP Partner at Wilson Sonsini Goodrich & Rosati

1:25 – 1:40

Break, Networking and Exhibitions
Session III (1:40 – 3:10 pm)

1:40 - 2:10

Novel Oral Therapy for the Treatment of Anemia of Kidney Disease Using Hypoxia Inducible Factor Stabilizer (FG-4592) presented by Dr. Peony Yu, Vice President of Clinical Development at FibroGen

2:10 – 2:40

High Sensitivity Isolation and Analysis of Rare Cells and Circulating Tumor Cells from Peripheral Blood presented by Dr. Daniel T. Chiu, the A. Bruce Montgomery Chemistry Professor and Professor of Bioengineering at the University of Washington

2:40 - 3:10

Biotherapeutics Process Development and Manufacturing Lifecycle Management presented by Dr. David Y.H. Chang, Senior Director of Department of Biologics Manufacturing Sciences and Technology and Packaging Development at Genentech

3:10 - 3:25

Coffee Break, Networking and Exhibitions
Session IV  (3:25 - 4:25 pm)

3:25 - 3:55

The Future of Bio-Interfacing for Consumers presented by Mr. Stanly Yang, CEO at NeuroSky

3:55 – 4:25

USP Elemental Impurities Initiatives and Current Status presented by
Dr. Assad J. Kazeminy, CEO and Founder at Irvine Pharmaceutical Services

4:25 - 4:30

Closing Remarks
Dr. Son Kuan